Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center ,Randomized, Double-Blind, Placebo-Controlled, Dose-Exploring Study to Evaluate the Efficacy and Safety of TPN171H in China Male Patients With Erectile Dysfunction

NCT04479917 is registered in ClinicalTrials.gov with Vigonvita Life Sciences as lead sponsor.

NCT NCT04479917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04479917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center ,Randomized, Double-Blind, Placebo-Controlled, Dose-Exploring Study to Evaluate the Efficacy and Safety of TPN171H in China Male Patients With Erectile Dysfunction
Lead sponsor
Vigonvita Life Sciences
Phase
Phase 2
Overall status
Completed
Start date
July 23, 2020
Completion date
July 26, 2021
Enrollment
255 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction